Related Experiment Videos

Hypertension in autosomal dominant polycystic kidney disease

A B Chapman¹, P A Gabow

¹Denver Health, Colorado, USA.

Kidney International. Supplement

|November 5, 1997

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Nighttime administration of high-dose, sustained-release melatonin does not decrease nocturnal blood pressure in African-American patients: Results from a preliminary randomized, crossover trial.

Complementary therapies in medicine·2019

Melatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation?

Clinical and translational science·2016

Transethnic meta-analysis suggests genetic variation in the HEME pathway influences potassium response in patients treated with hydrochlorothiazide.

The pharmacogenomics journal·2014

Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate.

Clinical pharmacology and therapeutics·2014

Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.

Journal of internal medicine·2014

Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.

The pharmacogenomics journal·2013

See all related articles